Updated data from a phase II dose finding trial of single agent isatuximab (SAR650984, anti-CD38 mAb) in relapsed/refractory multiple myeloma (RRMM) Meeting Abstract
| Authors: | Richter, J. R.; Martin, T. G.; Vij, R.; Cole, C.; Atanackovic, D.; Zonder, J. A.; Kaufman, J. L.; Mikhael, J.; Bensinger, W.; Dimopoulos, M. A.; Zimmerman, T. M.; Lendvai, N.; Hari, P.; Ocio, E. M.; Gasparetto, C.; Kumar, S.; Oprea, C.; Charpentier, E.; Strickland, S. A.; Miguel, J. S. |
| Abstract Title: | Updated data from a phase II dose finding trial of single agent isatuximab (SAR650984, anti-CD38 mAb) in relapsed/refractory multiple myeloma (RRMM) |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 417s |
| Language: | English |
| ACCESSION: | WOS:000404711505161 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.8005 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 8005 -- Source: Wos |
